Global Interventional Oncology Market Research Report 2023

Report ID: 1988452 | Published Date: Mar 2026 | No. of Page: 112 | Base Year: 2025 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Interventional Oncology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Ablation Devices
        1.2.3 Embolization Devices
        1.2.4 Support Devices
    1.3 Market by Application
        1.3.1 Global Interventional Oncology Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Liver Cancer
        1.3.3 Lung Cancer
        1.3.4 Kidney Cancer
        1.3.5 Bone Cancer
        1.3.6 Breast Cancer
        1.3.7 Prostate Cancer
        1.3.8 Pancreatic Cancer
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Interventional Oncology Market Perspective (2017-2028)
    2.2 Interventional Oncology Growth Trends by Region
        2.2.1 Interventional Oncology Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Interventional Oncology Historic Market Size by Region (2017-2022)
        2.2.3 Interventional Oncology Forecasted Market Size by Region (2023-2028)
    2.3 Interventional Oncology Market Dynamics
        2.3.1 Interventional Oncology Industry Trends
        2.3.2 Interventional Oncology Market Drivers
        2.3.3 Interventional Oncology Market Challenges
        2.3.4 Interventional Oncology Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Interventional Oncology Players by Revenue
        3.1.1 Global Top Interventional Oncology Players by Revenue (2017-2022)
        3.1.2 Global Interventional Oncology Revenue Market Share by Players (2017-2022)
    3.2 Global Interventional Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Interventional Oncology Revenue
    3.4 Global Interventional Oncology Market Concentration Ratio
        3.4.1 Global Interventional Oncology Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Revenue in 2021
    3.5 Interventional Oncology Key Players Head office and Area Served
    3.6 Key Players Interventional Oncology Product Solution and Service
    3.7 Date of Enter into Interventional Oncology Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Oncology Breakdown Data by Type
    4.1 Global Interventional Oncology Historic Market Size by Type (2017-2022)
    4.2 Global Interventional Oncology Forecasted Market Size by Type (2023-2028)
5 Interventional Oncology Breakdown Data by Application
    5.1 Global Interventional Oncology Historic Market Size by Application (2017-2022)
    5.2 Global Interventional Oncology Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Interventional Oncology Market Size (2017-2028)
    6.2 North America Interventional Oncology Market Size by Country (2017-2022)
    6.3 North America Interventional Oncology Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Interventional Oncology Market Size (2017-2028)
    7.2 Europe Interventional Oncology Market Size by Country (2017-2022)
    7.3 Europe Interventional Oncology Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Interventional Oncology Market Size (2017-2028)
    8.2 Asia-Pacific Interventional Oncology Market Size by Country (2017-2022)
    8.3 Asia-Pacific Interventional Oncology Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Interventional Oncology Market Size (2017-2028)
    9.2 Latin America Interventional Oncology Market Size by Country (2017-2022)
    9.3 Latin America Interventional Oncology Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Interventional Oncology Market Size (2017-2028)
    10.2 Middle East & Africa Interventional Oncology Market Size by Country (2017-2022)
    10.3 Middle East & Africa Interventional Oncology Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Boston Scientific
        11.1.1 Boston Scientific Company Detail
        11.1.2 Boston Scientific Business Overview
        11.1.3 Boston Scientific Interventional Oncology Introduction
        11.1.4 Boston Scientific Revenue in Interventional Oncology Business (2017-2022)
        11.1.5 Boston Scientific Recent Development
    11.2 BTG
        11.2.1 BTG Company Detail
        11.2.2 BTG Business Overview
        11.2.3 BTG Interventional Oncology Introduction
        11.2.4 BTG Revenue in Interventional Oncology Business (2017-2022)
        11.2.5 BTG Recent Development
    11.3 Medtronic
        11.3.1 Medtronic Company Detail
        11.3.2 Medtronic Business Overview
        11.3.3 Medtronic Interventional Oncology Introduction
        11.3.4 Medtronic Revenue in Interventional Oncology Business (2017-2022)
        11.3.5 Medtronic Recent Development
    11.4 Merit Medical
        11.4.1 Merit Medical Company Detail
        11.4.2 Merit Medical Business Overview
        11.4.3 Merit Medical Interventional Oncology Introduction
        11.4.4 Merit Medical Revenue in Interventional Oncology Business (2017-2022)
        11.4.5 Merit Medical Recent Development
    11.5 Terumo
        11.5.1 Terumo Company Detail
        11.5.2 Terumo Business Overview
        11.5.3 Terumo Interventional Oncology Introduction
        11.5.4 Terumo Revenue in Interventional Oncology Business (2017-2022)
        11.5.5 Terumo Recent Development
    11.6 Accuray
        11.6.1 Accuray Company Detail
        11.6.2 Accuray Business Overview
        11.6.3 Accuray Interventional Oncology Introduction
        11.6.4 Accuray Revenue in Interventional Oncology Business (2017-2022)
        11.6.5 Accuray Recent Development
    11.7 Alpinion Medical Systems
        11.7.1 Alpinion Medical Systems Company Detail
        11.7.2 Alpinion Medical Systems Business Overview
        11.7.3 Alpinion Medical Systems Interventional Oncology Introduction
        11.7.4 Alpinion Medical Systems Revenue in Interventional Oncology Business (2017-2022)
        11.7.5 Alpinion Medical Systems Recent Development
    11.8 Angiodynamics
        11.8.1 Angiodynamics Company Detail
        11.8.2 Angiodynamics Business Overview
        11.8.3 Angiodynamics Interventional Oncology Introduction
        11.8.4 Angiodynamics Revenue in Interventional Oncology Business (2017-2022)
        11.8.5 Angiodynamics Recent Development
    11.9 Atricure
        11.9.1 Atricure Company Detail
        11.9.2 Atricure Business Overview
        11.9.3 Atricure Interventional Oncology Introduction
        11.9.4 Atricure Revenue in Interventional Oncology Business (2017-2022)
        11.9.5 Atricure Recent Development
    11.10 Baylis Medical
        11.10.1 Baylis Medical Company Detail
        11.10.2 Baylis Medical Business Overview
        11.10.3 Baylis Medical Interventional Oncology Introduction
        11.10.4 Baylis Medical Revenue in Interventional Oncology Business (2017-2022)
        11.10.5 Baylis Medical Recent Development
    11.11 Bovie Medical
        11.11.1 Bovie Medical Company Detail
        11.11.2 Bovie Medical Business Overview
        11.11.3 Bovie Medical Interventional Oncology Introduction
        11.11.4 Bovie Medical Revenue in Interventional Oncology Business (2017-2022)
        11.11.5 Bovie Medical Recent Development
    11.12 Brainlab
        11.12.1 Brainlab Company Detail
        11.12.2 Brainlab Business Overview
        11.12.3 Brainlab Interventional Oncology Introduction
        11.12.4 Brainlab Revenue in Interventional Oncology Business (2017-2022)
        11.12.5 Brainlab Recent Development
    11.13 Bsd Medical
        11.13.1 Bsd Medical Company Detail
        11.13.2 Bsd Medical Business Overview
        11.13.3 Bsd Medical Interventional Oncology Introduction
        11.13.4 Bsd Medical Revenue in Interventional Oncology Business (2017-2022)
        11.13.5 Bsd Medical Recent Development
    11.14 C. R. Bard
        11.14.1 C. R. Bard Company Detail
        11.14.2 C. R. Bard Business Overview
        11.14.3 C. R. Bard Interventional Oncology Introduction
        11.14.4 C. R. Bard Revenue in Interventional Oncology Business (2017-2022)
        11.14.5 C. R. Bard Recent Development
    11.15 C2 Therapeutics
        11.15.1 C2 Therapeutics Company Detail
        11.15.2 C2 Therapeutics Business Overview
        11.15.3 C2 Therapeutics Interventional Oncology Introduction
        11.15.4 C2 Therapeutics Revenue in Interventional Oncology Business (2017-2022)
        11.15.5 C2 Therapeutics Recent Development
    11.16 Cardiofocus
        11.16.1 Cardiofocus Company Detail
        11.16.2 Cardiofocus Business Overview
        11.16.3 Cardiofocus Interventional Oncology Introduction
        11.16.4 Cardiofocus Revenue in Interventional Oncology Business (2017-2022)
        11.16.5 Cardiofocus Recent Development
    11.17 Cook Medical
        11.17.1 Cook Medical Company Detail
        11.17.2 Cook Medical Business Overview
        11.17.3 Cook Medical Interventional Oncology Introduction
        11.17.4 Cook Medical Revenue in Interventional Oncology Business (2017-2022)
        11.17.5 Cook Medical Recent Development
    11.18 Eckert And Ziegler Bebig
        11.18.1 Eckert And Ziegler Bebig Company Detail
        11.18.2 Eckert And Ziegler Bebig Business Overview
        11.18.3 Eckert And Ziegler Bebig Interventional Oncology Introduction
        11.18.4 Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2017-2022)
        11.18.5 Eckert And Ziegler Bebig Recent Development
    11.19 Edap Tms
        11.19.1 Edap Tms Company Detail
        11.19.2 Edap Tms Business Overview
        11.19.3 Edap Tms Interventional Oncology Introduction
        11.19.4 Edap Tms Revenue in Interventional Oncology Business (2017-2022)
        11.19.5 Edap Tms Recent Development
    11.20 Elekta
        11.20.1 Elekta Company Detail
        11.20.2 Elekta Business Overview
        11.20.3 Elekta Interventional Oncology Introduction
        11.20.4 Elekta Revenue in Interventional Oncology Business (2017-2022)
        11.20.5 Elekta Recent Development
    11.21 Galil Medical
        11.21.1 Galil Medical Company Detail
        11.21.2 Galil Medical Business Overview
        11.21.3 Galil Medical Interventional Oncology Introduction
        11.21.4 Galil Medical Revenue in Interventional Oncology Business (2017-2022)
        11.21.5 Galil Medical Recent Development
    11.22 Healthtronics
        11.22.1 Healthtronics Company Detail
        11.22.2 Healthtronics Business Overview
        11.22.3 Healthtronics Interventional Oncology Introduction
        11.22.4 Healthtronics Revenue in Interventional Oncology Business (2017-2022)
        11.22.5 Healthtronics Recent Development
    11.23 Insightec
        11.23.1 Insightec Company Detail
        11.23.2 Insightec Business Overview
        11.23.3 Insightec Interventional Oncology Introduction
        11.23.4 Insightec Revenue in Interventional Oncology Business (2017-2022)
        11.23.5 Insightec Recent Development
    11.24 Medwaves
        11.24.1 Medwaves Company Detail
        11.24.2 Medwaves Business Overview
        11.24.3 Medwaves Interventional Oncology Introduction
        11.24.4 Medwaves Revenue in Interventional Oncology Business (2017-2022)
        11.24.5 Medwaves Recent Development
    11.25 Mermaid Medical
        11.25.1 Mermaid Medical Company Detail
        11.25.2 Mermaid Medical Business Overview
        11.25.3 Mermaid Medical Interventional Oncology Introduction
        11.25.4 Mermaid Medical Revenue in Interventional Oncology Business (2017-2022)
        11.25.5 Mermaid Medical Recent Development
    11.26 Microsulis Medical
        11.26.1 Microsulis Medical Company Detail
        11.26.2 Microsulis Medical Business Overview
        11.26.3 Microsulis Medical Interventional Oncology Introduction
        11.26.4 Microsulis Medical Revenue in Interventional Oncology Business (2017-2022)
        11.26.5 Microsulis Medical Recent Development
    11.27 Monteris Medical
        11.27.1 Monteris Medical Company Detail
        11.27.2 Monteris Medical Business Overview
        11.27.3 Monteris Medical Interventional Oncology Introduction
        11.27.4 Monteris Medical Revenue in Interventional Oncology Business (2017-2022)
        11.27.5 Monteris Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Interventional Oncology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Ablation Devices
    Table 3. Key Players of Embolization Devices
    Table 4. Key Players of Support Devices
    Table 5. Global Interventional Oncology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Interventional Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Interventional Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Interventional Oncology Market Share by Region (2017-2022)
    Table 9. Global Interventional Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Interventional Oncology Market Share by Region (2023-2028)
    Table 11. Interventional Oncology Market Trends
    Table 12. Interventional Oncology Market Drivers
    Table 13. Interventional Oncology Market Challenges
    Table 14. Interventional Oncology Market Restraints
    Table 15. Global Interventional Oncology Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Interventional Oncology Market Share by Players (2017-2022)
    Table 17. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology as of 2021)
    Table 18. Ranking of Global Top Interventional Oncology Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Interventional Oncology Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Interventional Oncology Product Solution and Service
    Table 22. Date of Enter into Interventional Oncology Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Interventional Oncology Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Interventional Oncology Revenue Market Share by Type (2017-2022)
    Table 26. Global Interventional Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Interventional Oncology Revenue Market Share by Type (2023-2028)
    Table 28. Global Interventional Oncology Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Interventional Oncology Revenue Market Share by Application (2017-2022)
    Table 30. Global Interventional Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Interventional Oncology Revenue Market Share by Application (2023-2028)
    Table 32. North America Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Interventional Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Interventional Oncology Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Interventional Oncology Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Interventional Oncology Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Boston Scientific Company Detail
    Table 43. Boston Scientific Business Overview
    Table 44. Boston Scientific Interventional Oncology Product
    Table 45. Boston Scientific Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 46. Boston Scientific Recent Development
    Table 47. BTG Company Detail
    Table 48. BTG Business Overview
    Table 49. BTG Interventional Oncology Product
    Table 50. BTG Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 51. BTG Recent Development
    Table 52. Medtronic Company Detail
    Table 53. Medtronic Business Overview
    Table 54. Medtronic Interventional Oncology Product
    Table 55. Medtronic Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 56. Medtronic Recent Development
    Table 57. Merit Medical Company Detail
    Table 58. Merit Medical Business Overview
    Table 59. Merit Medical Interventional Oncology Product
    Table 60. Merit Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 61. Merit Medical Recent Development
    Table 62. Terumo Company Detail
    Table 63. Terumo Business Overview
    Table 64. Terumo Interventional Oncology Product
    Table 65. Terumo Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 66. Terumo Recent Development
    Table 67. Accuray Company Detail
    Table 68. Accuray Business Overview
    Table 69. Accuray Interventional Oncology Product
    Table 70. Accuray Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 71. Accuray Recent Development
    Table 72. Alpinion Medical Systems Company Detail
    Table 73. Alpinion Medical Systems Business Overview
    Table 74. Alpinion Medical Systems Interventional Oncology Product
    Table 75. Alpinion Medical Systems Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 76. Alpinion Medical Systems Recent Development
    Table 77. Angiodynamics Company Detail
    Table 78. Angiodynamics Business Overview
    Table 79. Angiodynamics Interventional Oncology Product
    Table 80. Angiodynamics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 81. Angiodynamics Recent Development
    Table 82. Atricure Company Detail
    Table 83. Atricure Business Overview
    Table 84. Atricure Interventional Oncology Product
    Table 85. Atricure Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 86. Atricure Recent Development
    Table 87. Baylis Medical Company Detail
    Table 88. Baylis Medical Business Overview
    Table 89. Baylis Medical Interventional Oncology Product
    Table 90. Baylis Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 91. Baylis Medical Recent Development
    Table 92. Bovie Medical Company Detail
    Table 93. Bovie Medical Business Overview
    Table 94. Bovie Medical Interventional OncologyProduct
    Table 95. Bovie Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 96. Bovie Medical Recent Development
    Table 97. Brainlab Company Detail
    Table 98. Brainlab Business Overview
    Table 99. Brainlab Interventional OncologyProduct
    Table 100. Brainlab Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 101. Brainlab Recent Development
    Table 102. Bsd Medical Company Detail
    Table 103. Bsd Medical Business Overview
    Table 104. Bsd Medical Interventional OncologyProduct
    Table 105. Bsd Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 106. Bsd Medical Recent Development
    Table 107. C. R. Bard Company Detail
    Table 108. C. R. Bard Business Overview
    Table 109. C. R. Bard Interventional OncologyProduct
    Table 110. C. R. Bard Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 111. C. R. Bard Recent Development
    Table 112. C2 Therapeutics Company Detail
    Table 113. C2 Therapeutics Business Overview
    Table 114. C2 Therapeutics Interventional OncologyProduct
    Table 115. C2 Therapeutics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 116. C2 Therapeutics Recent Development
    Table 117. Cardiofocus Company Detail
    Table 118. Cardiofocus Business Overview
    Table 119. Cardiofocus Interventional OncologyProduct
    Table 120. Cardiofocus Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 121. Cardiofocus Recent Development
    Table 122. Cook Medical Company Detail
    Table 123. Cook Medical Business Overview
    Table 124. Cook Medical Interventional OncologyProduct
    Table 125. Cook Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 126. Cook Medical Recent Development
    Table 127. Eckert And Ziegler Bebig Company Detail
    Table 128. Eckert And Ziegler Bebig Business Overview
    Table 129. Eckert And Ziegler Bebig Interventional OncologyProduct
    Table 130. Eckert And Ziegler Bebig Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 131. Eckert And Ziegler Bebig Recent Development
    Table 132. Edap Tms Company Detail
    Table 133. Edap Tms Business Overview
    Table 134. Edap Tms Interventional OncologyProduct
    Table 135. Edap Tms Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 136. Edap Tms Recent Development
    Table 137. Elekta Company Detail
    Table 138. Elekta Business Overview
    Table 139. Elekta Interventional OncologyProduct
    Table 140. Elekta Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 141. Elekta Recent Development
    Table 142. Galil Medical Company Detail
    Table 143. Galil Medical Business Overview
    Table 144. Galil Medical Interventional OncologyProduct
    Table 145. Galil Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 146. Galil Medical Recent Development
    Table 147. Healthtronics Company Detail
    Table 148. Healthtronics Business Overview
    Table 149. Healthtronics Interventional OncologyProduct
    Table 150. Healthtronics Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 151. Healthtronics Recent Development
    Table 152. Insightec Company Detail
    Table 153. Insightec Business Overview
    Table 154. Insightec Interventional OncologyProduct
    Table 155. Insightec Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 156. Insightec Recent Development
    Table 157. Medwaves Company Detail
    Table 158. Medwaves Business Overview
    Table 159. Medwaves Interventional OncologyProduct
    Table 160. Medwaves Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 161. Medwaves Recent Development
    Table 162. Mermaid Medical Company Detail
    Table 163. Mermaid Medical Business Overview
    Table 164. Mermaid Medical Interventional OncologyProduct
    Table 165. Mermaid Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 166. Mermaid Medical Recent Development
    Table 167. Microsulis Medical Company Detail
    Table 168. Microsulis Medical Business Overview
    Table 169. Microsulis Medical Interventional OncologyProduct
    Table 170. Microsulis Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 171. Microsulis Medical Recent Development
    Table 172. Monteris Medical Company Detail
    Table 173. Monteris Medical Business Overview
    Table 174. Monteris Medical Interventional OncologyProduct
    Table 175. Monteris Medical Revenue in Interventional Oncology Business (2017-2022) & (US$ Million)
    Table 176. Monteris Medical Recent Development
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Interventional Oncology Market Share by Type: 2021 VS 2028
    Figure 2. Ablation Devices Features
    Figure 3. Embolization Devices Features
    Figure 4. Support Devices Features
    Figure 5. Global Interventional Oncology Market Share by Application in 2021 & 2028
    Figure 6. Liver Cancer Case Studies
    Figure 7. Lung Cancer Case Studies
    Figure 8. Kidney Cancer Case Studies
    Figure 9. Bone Cancer Case Studies
    Figure 10. Breast Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Pancreatic Cancer Case Studies
    Figure 13. Interventional Oncology Report Years Considered
    Figure 14. Global Interventional Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Interventional Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Interventional Oncology Market Share by Region: 2021 VS 2028
    Figure 17. Global Interventional Oncology Market Share by Players in 2021
    Figure 18. Global Top Interventional Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Oncology as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Interventional Oncology Revenue in 2021
    Figure 20. North America Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Interventional Oncology Market Share by Country (2017-2028)
    Figure 22. United States Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Interventional Oncology Market Share by Country (2017-2028)
    Figure 26. Germany Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Interventional Oncology Market Share by Region (2017-2028)
    Figure 34. China Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Interventional Oncology Market Share by Country (2017-2028)
    Figure 42. Mexico Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Interventional Oncology Market Share by Country (2017-2028)
    Figure 46. Turkey Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Interventional Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Boston Scientific Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 49. BTG Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 50. Medtronic Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 51. Merit Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 52. Terumo Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 53. Accuray Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 54. Alpinion Medical Systems Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 55. Angiodynamics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 56. Atricure Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 57. Baylis Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 58. Bovie Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 59. Brainlab Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 60. Bsd Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 61. C. R. Bard Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 62. C2 Therapeutics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 63. Cardiofocus Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 64. Cook Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 65. Eckert And Ziegler Bebig Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 66. Edap Tms Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 67. Elekta Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 68. Galil Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 69. Healthtronics Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 70. Insightec Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 71. Medwaves Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 72. Mermaid Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 73. Microsulis Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 74. Monteris Medical Revenue Growth Rate in Interventional Oncology Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific
BTG
Medtronic
Merit Medical
Terumo
Accuray
Alpinion Medical Systems
Angiodynamics
Atricure
Baylis Medical
Bovie Medical
Brainlab
Bsd Medical
C. R. Bard
C2 Therapeutics
Cardiofocus
Cook Medical
Eckert And Ziegler Bebig
Edap Tms
Elekta
Galil Medical
Healthtronics
Insightec
Medwaves
Mermaid Medical
Microsulis Medical
Monteris Medical
Frequently Asked Questions
Interventional Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Interventional Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Interventional Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Intimate Wash

Intimate Wash market is segmented by players, region (country), by Type and by Application. Playe ... Read More